Logo
x

Search category

Subscribe Now

SOD1 mutations

Biogen Exercises Exclusive Worldwide Option to Develop & Commercialize Ionis's BIIB067 (IONIS-SOD1RX) for Amyotrophic Lateral Sclerosis (ALS)

Biogen Exercises Exclusive Worldwide Option to Develop & Commercialize Ionis's BIIB067 (IONIS-SOD1RX) for Amyotrophic Lateral...

  • December 7, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.